Literature DB >> 26504618

Bone health in HIV-infected children, adolescents and young adults: a systematic review.

Stephen M Arpadi1, Stephanie Shiau2, Charlotte Marx-Arpadi3, Michael T Yin4.   

Abstract

BACKGROUND: Children and adolescents, who either acquire HIV infection perinatally, from contaminated blood products or via sexual transmission early in life, have the greatest cumulative exposure to the negative direct and indirect effects of HIV infection and ART on bone, which may lead to increased lifetime risk for osteoporosis and fracture. We conducted a systematic review to evaluate the literature on bone health in children and adolescents with HIV.
METHODS: We performed a comprehensive search of the Medline, Scopus, and Cochrane Library databases (up to April 1, 2014) for studies that reported on bone imaging or bone fractures in HIV-infected children, adolescents, or young adults.
RESULTS: A total of 32 publications met our inclusion criteria. Seventeen studies were cross-sectional and 15 were longitudinal. The majority of studies were conducted in high-income countries, three in middle-income countries and none in low-income countries. Overall, the studies we reviewed indicate that measures of bone mass are reduced, with increased prevalence of low BMD in children and adolescents with HIV. However, the studies are highly variable with respect to comparison sources, measurement methods, adjustment techniques for body size or growth retardation, and highlighted risk factors, including aspects related to medication exposures as well as the effects of HIV infection per se.
CONCLUSION: HIV infection appears to be associated with decreased bone accrual throughout childhood and adolescence. Initial studies indicate that sub-optimal bone accrual may be persistent and result in reduced peak bone mass, an important determinant of future risk of osteoporosis and fracture. Important areas for future research include evaluation of bone mass, bone quality and fracture risk across the life course among those with early-life infection with HIV, particularly in resource-limited settings where the majority of children with HIV live.

Entities:  

Year:  2014        PMID: 26504618      PMCID: PMC4618404          DOI: 10.4172/2155-6113.1000374

Source DB:  PubMed          Journal:  J AIDS Clin Res


  89 in total

1.  TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.

Authors:  B R Wong; D Besser; N Kim; J R Arron; M Vologodskaia; H Hanafusa; Y Choi
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

2.  Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation.

Authors:  Gregor F Lichtfuss; Wan-Jung Cheng; Yagmur Farsakoglu; Geza Paukovics; Reena Rajasuriar; Pushparaj Velayudham; Marit Kramski; Anna C Hearps; Paul U Cameron; Sharon R Lewin; Suzanne M Crowe; Anthony Jaworowski
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

3.  Antiretroviral therapy and bone mineral measurements in HIV-infected youths.

Authors:  Gianvincenzo Zuccotti; Alessandra Viganò; Clara Gabiano; Vania Giacomet; Federica Mignone; Sara Stucchi; Valeria Manfredini; Francesca Marinacci; Stefano Mora
Journal:  Bone       Date:  2010-03-06       Impact factor: 4.398

Review 4.  Residual immune dysregulation syndrome in treated HIV infection.

Authors:  Michael M Lederman; Nicholas T Funderburg; Rafick P Sekaly; Nichole R Klatt; Peter W Hunt
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

5.  Bone metabolism in children with human immunodeficiency virus infection receiving highly active anti-retroviral therapy including a protease inhibitor.

Authors:  B M Tan; R P Nelson; M James-Yarish; P J Emmanuel; S J Schurman
Journal:  J Pediatr       Date:  2001-09       Impact factor: 4.406

6.  Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Authors:  Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek
Journal:  J Infect Dis       Date:  2011-01-20       Impact factor: 5.226

7.  Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus.

Authors:  Julia B Purdy; Rachel I Gafni; James C Reynolds; Steven Zeichner; Rohan Hazra
Journal:  J Pediatr       Date:  2008-04       Impact factor: 4.406

Review 8.  Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism.

Authors:  I Zofková
Journal:  Physiol Res       Date:  2003       Impact factor: 1.881

9.  Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children.

Authors:  Babette S Zemel; Mary B Leonard; Andrea Kelly; Joan M Lappe; Vicente Gilsanz; Sharon Oberfield; Soroosh Mahboubi; John A Shepherd; Thomas N Hangartner; Margaret M Frederick; Karen K Winer; Heidi J Kalkwarf
Journal:  J Clin Endocrinol Metab       Date:  2010-01-26       Impact factor: 5.958

10.  Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.

Authors:  Denise L Jacobson; Jane C Lindsey; Catherine M Gordon; Jack Moye; Dana S Hardin; Kathleen Mulligan; Grace M Aldrovandi
Journal:  AIDS       Date:  2010-03-13       Impact factor: 4.177

View more
  10 in total

Review 1.  HIV and Bone Complications: Understudied Populations and New Management Strategies.

Authors:  Michael T Yin; Todd T Brown
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

2.  Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy.

Authors:  Julie J Kim-Chang; Lorena Wilson; Cliburn Chan; Bernard Fischer; Guglielmo Venturi; Maureen M Goodenow; Grace Aldrovandi; Thomas J Weber; John W Sleasman
Journal:  AIDS Res Hum Retroviruses       Date:  2019-06-27       Impact factor: 2.205

3.  Healthcare resource utilization and costs associated with renal, bone and cardiovascular comorbidities among persons living with HIV compared to the general population in Quebec, Canada.

Authors:  Véronique Baribeau; Connie J Kim; René-Pierre Lorgeoux; Josée Brisebois; Harout Tossonian; Jean Lachaine
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

Review 4.  Adverse bone health among children and adolescents growing up with HIV.

Authors:  Tavitiya Sudjaritruk; Thanyawee Puthanakit
Journal:  J Virus Erad       Date:  2015-07-01

5.  Older age at initiation of antiretroviral therapy predicts low bone mineral density in children with perinatally-infected HIV in Zimbabwe.

Authors:  Celia L Gregson; April Hartley; Edith Majonga; Grace McHugh; Nicola Crabtree; Ruramayi Rukuni; Tsitsi Bandason; Cynthia Mukwasi-Kahari; Kate A Ward; Hilda Mujuru; Rashida A Ferrand
Journal:  Bone       Date:  2019-05-10       Impact factor: 4.398

6.  Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration.

Authors:  Julie Jesson; Michael Schomaker; Karen Malasteste; Dewi K Wati; Azar Kariminia; Mariam Sylla; Kouakou Kouadio; Shobna Sawry; Mwangelwa Mubiana-Mbewe; Samuel Ayaya; Rachel Vreeman; Catherine C McGowan; Marcel Yotebieng; Valériane Leroy; Mary-Ann Davies
Journal:  J Int AIDS Soc       Date:  2019-11       Impact factor: 5.396

7.  Profiling of Inflammatory Proteins in Plasma of HIV-1-Infected Children Receiving Antiretroviral Therapy.

Authors:  Mahlet Lemma; Stefan Petkov; Yonas Bekele; Beyene Petros; Rawleigh Howe; Francesca Chiodi
Journal:  Proteomes       Date:  2020-09-07

8.  Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial.

Authors:  Nyasha Veronica Dzavakwa; Molly Chisenga; Grace McHugh; Suzanne Filteau; Celia Louise Gregson; Lackson Kasonka; Katharina Kranzer; Hildah Banda Mabuda; Hilda Mujuru; Nicol Redzo; Sarah Rowland-Jones; Ulrich E Schaible; Victoria Simms; Rashida Abbas Ferrand
Journal:  Trials       Date:  2022-01-26       Impact factor: 2.279

9.  Comparison of quantitative ultrasonography and dual X-ray absorptiometry for bone status assessment in South African children living with HIV.

Authors:  Jackson A Roberts; Yanhan Shen; Renate Strehlau; Faeezah Patel; Louise Kuhn; Ashraf Coovadia; Jonathan J Kaufman; Stephanie Shiau; Stephen M Arpadi; Michael T Yin
Journal:  PLoS One       Date:  2022-10-17       Impact factor: 3.752

10.  The IMpact of Vertical HIV infection on child and Adolescent SKeletal development in Harare, Zimbabwe (IMVASK Study): a protocol for a prospective cohort study.

Authors:  Ruramayi Rukuni; Celia Gregson; Cynthia Kahari; Farirayi Kowo; Grace McHugh; Shungu Munyati; Hilda Mujuru; Kate Ward; Suzanne Filteau; Andrea M Rehman; Rashida Ferrand
Journal:  BMJ Open       Date:  2020-02-09       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.